Perrigo CO PLC

Market Movers (8-K)

NYSE
Perrigo Company plc amends prior 8-K filing to detail the employment agreement for Albert Manzone as Interim President and Chief Executive Officer, including salary, bonus, and equity grants.
NYSE
Perrigo Company plc has reinstated its Executive Committee Severance Policy, offering enhanced benefits to executive officers during a leadership transition period.
NYSE
Perrigo Company plc announced the appointment of Salman Amin and Omer Gajial as independent directors to its Board, effective June 30, 2026, expanding the board to ten members.
NYSE
Perrigo Company plc announced the immediate resignation of its President and CEO, Patrick Lockwood-Taylor, due to personal conduct inconsistent with the company's code of conduct, appointing Albert A. Manzone as interim CEO.
NYSE
Perrigo Company plc announced first quarter 2026 financial results, showing progress on its ThreeS plan despite category headwinds, and reaffirmed its full-year guidance.
Worse than expected
NYSE
Perrigo Company plc's 2026 Annual General Meeting saw shareholders approve the new 2026 Long-Term Incentive Plan, re-elect directors, and ratify auditor appointment.

Quarterly Earnings (10-Q)

NYSE
Perrigo Company plc reported a significant improvement in net income for Q3 2025, turning a prior-year loss into a profit, despite a decline in net sales, as strategic restructuring and divestitures continue.
Better than expected
Delay expected
NYSE
Perrigo Company plc significantly reduced its net loss and achieved positive operating income in the second quarter of 2025, driven by cost-cutting initiatives and lower impairment charges.
Better than expected
NYSE
Perrigo grants service-based and performance-based restricted stock units to participants under its 2019 Long-Term Incentive Plan.
Delay expected
Worse than expected
NYSE
Perrigo's Q3 results show a decrease in net sales but an increase in operating income, influenced by strategic divestitures and ongoing restructuring efforts.
Worse than expected
NYSE
Perrigo's second quarter results show a net loss, impacted by restructuring charges and lower sales in key categories, despite some gains in specific product lines.
Worse than expected
NYSE
Perrigo's first quarter results show a decrease in net sales and operating income, influenced by strategic initiatives and market factors, including challenges in the infant formula sector.
Worse than expected

Annual Reports (10-K)

NYSE
Perrigo Company plc reported a substantial net loss of $1.425 billion in 2025, primarily driven by $1.363 billion in goodwill impairment charges, alongside ongoing strategic reviews and operational enhancements.
Worse than expected
Delay expected
NYSE
Perrigo's 2024 10-K filing highlights its strategic shift towards self-care, global portfolio streamlining, and investments in high-growth brands.
Worse than expected
NYSE
Perrigo's 2023 10-K filing details its extensive network of subsidiaries, financial performance, and strategic initiatives in the self-care market.
Worse than expected

Insider Trading (Form 4)

NYSE
Albert Manzone, Interim President and CEO and a Director of PERRIGO Co plc, received 235,627 shares of common stock on July 8, 2026.
NYSE
Ahmed Salman Amin, a Director of PERRIGO Co plc, received 14,964 shares of common stock on July 8, 2026.
NYSE
Muhammad Omer Gajial, a Director of PERRIGO Co plc, received 14,964 shares of common stock on July 8, 2026.
NYSE
Perrigo Co plc EVP & CFO Eduardo Bezerra acquired 141,376 ordinary shares through restricted stock units.
NYSE
Perrigo Company plc executive Roberto Khoury reports the vesting of restricted stock units, converting them into ordinary shares.
NYSE
Perrigo Company plc executive David Ball reported the vesting of 70,688 Restricted Stock Units, converting them into ordinary shares.

Proxy Statements (Def-14A)

NYSE
Perrigo's 2026 proxy statement reveals mixed 2025 financial results, strategic progress on its 3-S plan, and proposals for the upcoming Annual General Meeting, including a new Long-Term Incentive Plan.
Capital raise
NYSE
Perrigo Company plc will hold its Annual Meeting of Shareholders on May 1, 2025, to vote on director elections, auditor ratification, executive compensation, and other corporate governance matters.
NYSE
Perrigo announces its 2025 Annual General Meeting (AGM) will be held on May 1, 2025, featuring proposals on director elections, auditor ratification, executive compensation, and more.
NYSE
Perrigo Company PLC will hold its Annual General Meeting of Shareholders on May 2, 2024, to vote on key proposals including the election of directors, ratification of the auditor, executive compensation, and renewal of board authorities.
NYSE
Perrigo Company plc will hold its 2024 Annual General Meeting on May 2, 2024, to vote on the election of directors, ratification of the auditor, executive compensation, and renewal of the Board's authority to issue shares.
Better than expected

Schedule 13G - Passive Investments

NYSE
T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.2% of Perrigo Co PLC's common stock as of April 30, 2026.
NYSE
T. Rowe Price Associates, Inc. has reported a beneficial ownership of 9.7% in Perrigo Co PLC, holding over 13.3 million shares as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.99% of Perrigo Co PLC's common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has disclosed beneficial ownership of 7,260,072 shares, representing 5.27% of the outstanding common stock of Perrigo Co PLC.
NYSE
Dimensional Fund Advisors LP has filed a Schedule 13G, reporting beneficial ownership of 4.8% of Perrigo Co PLC's common stock as of March 31, 2026.
NYSE
The Vanguard Group reported a 0% beneficial ownership in Perrigo Co PLC common stock following an internal realignment that disaggregated its reporting.